Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
KILITCH.NSthis companyKilitch Drugs (India) Limited	₹200.54	13.97×	1.51×	1.79×	10.31×	-261.5%	38.8%	14.0%	12.8%	10.8%	6.9%	-19.1%	0.32×	1.5×	5.93×	1.83×	0.0%	2	—	2	C+
ININDSWFTLAB.BOInd-Swift Laboratories Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
INDSWFTLAB.NSInd-Swift Laboratories Limited	₹349.05	26.55×	0.79×	1.71×	15.31×	-42.2%	29.7%	2.3%	6.5%	3.0%	0.9%	-9.8%	0.01×	-9.08×	10.31×	3.8×	0.0%	2	7.26	3	B
KOKOPRAN.BOKopran Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
SAKAR.NSSakar Healthcare Limited	₹1,028.65	36.38×	3.42×	4.41×	16.36×	-280.7%	26.3%	18.0%	12.1%	9.4%	8.8%	1.0%	0.17×	0.77×	5.77×	1.28×	0.0%	6	8.41	3	B
SGRL.BOShree Ganesh Remedies Limited	₹607.55	30.37×	3.31×	4.94×	14.63×	-127.1%	41.7%	22.5%	16.3%	10.9%	9.3%	0.7%	0.19×	0.46×	6.89×	3.96×	0.0%	3	—	1	C-
Peer median	—	30.37×	3.31×	4.41×	15.31×	-127.1%	29.7%	18.0%	12.1%	9.4%	8.8%	0.7%	0.17×	0.46×	6.89×	3.8×	0.0%	3	7.83	3	—